top of page
GLOWBRIDGE NEWS
A closer look at what comes next.
Insights on Korean manufacturing, K-beauty OEM/ODM, wellness devices, food, and dietary supplements—connecting product development and regulatory preparation with U.S. business growth.


The Next K-Beauty Winner Won’t Be Another Face Serum The numbers are pointing somewhere new
For years, Korean beauty earned its U.S. reputation on the face: serums, essences, moisturizers, sunscreens. Facial care is still healthy. Face creams, cleansers, and eye treatments all posted solid growth in the first half of 2026. But the fastest growth is now happening in other places. According to Circana’s H1 2026 report on U.S. prestige retail (vs. H1 2025): Prestige skincare: +9%, the fastest-growing prestige beauty category, rebounding after a softer 2025 Body care: +
3 min read


FDA Finalizes Mandatory Cosmetics Recall Guidance: What K-Beauty Brands Entering the U.S. Should Know
The U.S. Food and Drug Administration (FDA) has finalized its guidance on Mandatory Cosmetics Recalls, providing more clarity on how the agency may exercise its recall authority under the Modernization of Cosmetics Regulation Act of 2022 (MoCRA). The final guidance, issued in October 2026, addresses common questions about the criteria, process, and expectations surrounding mandatory recalls of cosmetic products. For Korean beauty brands planning to enter the U.S. market, the
4 min read


K-Beauty Exports Hit a New Record. Here’s What That Means for Your FDA Compliance
South Korea’s cosmetics industry just posted another record. According to Korean government export data for September 2026, as reported by Beauty Nury, monthly cosmetics exports passed $1.5 billion for the first time. The numbers at a glance September 2026: $1.506 billion, up 31.4% from a year earlier and the highest monthly total on record. January to September: $11.139 billion, up 31.2% year over year. Third quarter: $4.165 billion, up 39.3%. This is the first quarter above
2 min read


GlowBridge CEO Sung Kwon to Speak at Cosmoprof Asia Hong Kong 2026
GlowBridge is pleased to share that Sung Kwon, CEO of GlowBridge, will be participating as a speaker at Cosmoprof Asia Hong Kong 2026, one of Asia’s major international beauty industry events. Sung Kwon will join the session: K-Beauty 3.0: Asia’s Innovation Powerhouses Captivating Gen Z Date: November 12, 2026 Time: 3:00–3:45 PM HKT (UTC+8) Location: Hong Kong Convention & Exhibition Centre The session will explore how the next generation of K-Beauty is evolving through produ
1 min read


Neutrogena Just Made "K-Beauty Inspired" Sunscreen Mainstream
Something important just happened in the U.S. sunscreen market. On September 17, 2026, Neutrogena launched two new facial sunscreens featuring bemotrizinol (BEMT) — the first new sunscreen active ingredient added to the U.S. OTC sunscreen monograph since the late 1990s. But the regulatory milestone isn't the only reason this launch deserves attention. Neutrogena is explicitly describing its new technology as "K-Beauty inspired." That makes this launch a meaningful signal for
4 min read


When AI Writes the GMP Document: What the FDA's Purolea Warning Letter Means for Beauty Brands
Artificial intelligence is quickly becoming part of everyday business operations — from product research and regulatory searches to SOP drafting and quality documentation. A recent FDA Warning Letter involving a Michigan drug manufacturer highlights an important boundary: AI can help create a document. It cannot take responsibility for the document. On April 2, 2026, FDA issued Warning Letter 320-26-58 to Purolea Cosmetics Lab, a Livonia, MI-based manufacturer, following a th
5 min read


FDA Sunscreen Regulation Is Moving: What PABA, Trolamine Salicylate and Bemotrizinol Mean for K-Beauty
For Korean beauty brands planning to enter or expand in the U.S. market, sunscreen deserves particular regulatory attention. In September 2026, the U.S. Food and Drug Administration (FDA) issued a final administrative order amending OTC Monograph M020 for sunscreen drug products. The order removes PABA (aminobenzoic acid) and trolamine salicylate as permitted sunscreen active ingredients because FDA determined that the ingredients are not generally recognized as safe and effe
3 min read


Can a “Learn More” Link Become a Regulatory Risk?
When brands think about cosmetic compliance in the U.S., they usually think about the obvious things first. The product label.The ingredient list.The claims on the product page.The packaging. But there is another area that can be surprisingly easy to overlook: The content you link to. Imagine a brand selling an arnica balm. The brand itself never says that the product “heals bruises” or “relieves muscle pain.” Instead, its website includes a simple message: “Want to learn mor
4 min read


What Torriden’s Regulatory Move Says About the Next Stage of K-Beauty in the U.S.
K-Beauty has changed. A few years ago, the conversation was largely about whether Korean beauty products could become popular among American consumers. Today, that question has largely been answered. K-Beauty is already a major part of the U.S. beauty conversation. The next question is different: Can Korean beauty brands build the infrastructure needed to grow sustainably in the United States? That is why Torriden’s recent decision to onboard Provision Consulting Group for U.
3 min read
bottom of page
